Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer

Annals of Oncology

Volumn 12, Issue 3, 2001, Pages 343-347

  Mantz, C A ^a   Vokes, E E ^a   Kies, M S ^b   Mittal, B ^c   Witt, M E ^a   List, M A ^a   Weichselbaum, R R ^a   Haraf, D J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemoradiotherapy; Chemotherapy; Laryngeal cancer

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LARYNGECTOMY; LARYNX CANCER; MALE; MINIMAL RESIDUAL DISEASE; PHASE 2 CLINICAL TRIAL; PRESERVATION; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REGIONALIZATION; SURVIVAL TIME; TOXICITY; TREATMENT FAILURE; TREATMENT OUTCOME; VOICE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035070206     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011188726802     Document Type: Article

References (20)

1. Cancer of the larynx: Supraglottic cancer
2. The evaluation of treatment of patients with extensive squamous cancer of the vocal cords
3. 3 squamous-cell carcinoma of the glottic larynx: A comparison of laryngectomy and irradiation
4. 3 glottic cancer
5. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer
6. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
7. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
8. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
9. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
10. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous-cell report of RTOG 9003
11. Cisplatin, fluorouracil, and leucovorin augmented by interferon-α2b in head and neck cancer: A clinical and pharmacologic analysis
12. Favorable long-term survival following induction chemotherapy with PFL and concomitant chemoradiotherapy for locally advanced head and neck cancer
13. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease
14. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival
15. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X-rays
16. Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer
17. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M.D. Anderson Cancer Center experience
18. Fractionation with X-rays and neutrons in mice: Response of skin and C3H mammary tumours
19. Dose-time considerations of head and neck squamous-cell carcinomas treated with irradiation
20. Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer